Profil
Leonard Scott Dove is a former Director-Compound Partnering at Pharmaceutical Product Development LLC.
He was also an Executive Director-Clinical Development at Allergan Ltd. (Ireland) from 2015 to 2017.
From 2017 to 2022, he served as the Senior Vice President & General Manager at PPD, Inc. Most recently, in 2022, he held the position of Chief Operating Officer at Aravive, Inc. Dr. Dove obtained his undergraduate and doctorate degrees from Texas A&M University.
Tidigare kända positioner av Leonard Dove
| Företag | Position | Slut |
|---|---|---|
| ARAVIVE, INC. | Verksamhetschef | 2023-08-01 |
| PPD, INC. | Företagsledare/Principal | 2022-03-01 |
| ALLERGAN PLC | Teknisk/Vetenskaplig/F&U Direktör | 2017-11-01 |
Pharmaceutical Product Development LLC
Pharmaceutical Product Development LLC Miscellaneous Commercial ServicesCommercial Services Operates as a contract research organization for life-changing therapies | Företagsledare/Principal | - |
Leonard Doves utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Pharmaceutical Product Development LLC
Pharmaceutical Product Development LLC Miscellaneous Commercial ServicesCommercial Services Operates as a contract research organization for life-changing therapies | Commercial Services |
Texas A&M University
Texas A&M University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Allergan Ltd. (Ireland)
Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes pharmaceuticals, devices, biological, surgical & regenerative medicine products | Health Technology |
PPD, Inc.
PPD, Inc. BiotechnologyHealth Technology Engages in research and development of biopharmaceutical industry | Health Technology |
Aravive, Inc.
Aravive, Inc. BiotechnologyHealth Technology Develops therapies for solid tumors and hematologic malignancies | Health Technology |
















